Does hormone replacement therapy discontinuation cause musculoskeletal pain?

Joint Bone Spine

Volumn 73, Issue 5, 2006, Pages 488-489

  Kahn, Marcel Francis ^a  

^a NONE   (France)

Author keywords

Arthromyalgia; Estrogens; Postmenopausal arthritis

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; ESTROGEN; HORMONE; RALOXIFENE; TAMOXIFEN;

ARTHRALGIA; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; FIBROMYALGIA; HORMONE SUBSTITUTION; HUMAN; LEG PAIN; MENOPAUSE; MUSCULOSKELETAL PAIN; MYALGIA; NONHUMAN; OSTEOPOROSIS; PAIN; POSTMENOPAUSE; TREATMENT WITHDRAWAL; ESTROGEN THERAPY; FEMALE; MUSCULOSKELETAL DISEASE;

ESTROGEN REPLACEMENT THERAPY; FEMALE; FIBROMYALGIA; HUMANS; MENOPAUSE; MUSCULOSKELETAL DISEASES;

EID: 33750578295     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.03.004     Document Type: Editorial

References (17)

1. Felson D.T., and Cummings S.R. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum. 52 (2005) 2594-2598
2. Ribot C., Tremollieres F., and Pouilles J.M. Aromatase and regulation of bone remodeling. Joint Bone Spine 73 (2006) 37-42
3. Fontanges E., Fontana A., and Delmas P. Osteoporosis and breast cancer. Joint Bone Spine 71 (2004) 102-110
4. Donnllan P.P., Douglas S.L., Cameron D.A., and Leonard R.C. Aromatase inhibitors and arthralgias (letter). J. Clin. Oncol. 19 (2001) 2767
5. Buzdar A., Douma J., Davidson N., Elledge P., Morgan M., Smith R., et al. Phase III multicenter double-blinded, randomised study of letrazole, an aromatase inhibitor for advanced breast cancer versus mestrol acetate. J. Clin. Oncol. 19 (2001) 3357-3366
6. Goss P.E., Ingle J.N., Martino S., Robert N.J., Muss H.B., Piccart M.J., et al. A randomised trial of letrazole in post menopausal women after five years of tamoxifen therapy for early-stage breast cancer. New Engl J Med 349 (2003) 1793-1802
7. Comroe B.L. Henry Kimpton Publishers (1944), Arthritis and Allied Conditions, London 516-521
8. Shim G.J., Warner M., Kim H.J., Anderson S., Liu L., Ekman J., et al. Aromatase deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren syndrome. Proc. Natl. Acad. Sci. USA 101 (2004) 12628-12633
9. Waxman J., and Zatzkis S.M. Fibromyalgia and menopause. Examination of the relationship. Postgrad. Med. 80 (1986) 165-171
10. Pamuk O.N., and Çäkir N. The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin. Exp. Rheumatol. 23 (2005) 778-782
11. Blomqvist A. Sex hormones and pain: a new role for brain aromatase?. J. Comp. Neurol. 423 (2000) 549-551
12. Salem M.L. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy 3 (2004) 97-104
13. Cutolo M., and Lahita R.G. Estrogens and arthritis. Rheum. Dis. Clin. North Am. 31 (2005) 19-27
14. Flores C.A., Shughrue P., Petersen S.L., and Mokha S.S. Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat. Neuroscience 118 (2003) 769-778
15. Macfarlane T.V., Blinkhorn A., Worthington H.V., Davies R.M., and Macfarlane G.J. Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatol. 41 (2002) 454-457
16. Benichou O., Orcel P., and Lemaire V. Ostéoporose et modulateurs sélectifs du récepteur des estrogènes. In: Kahn M.F., Kuntz D., Meyer O., Bardin T., and Orcel P. (Eds). L'Actualité rhumatologique (1999), Elsevier, Paris 311-322
17. Anderberg U.M. Comment on: Johns and Littlejohn, the role of sex hormones in pain response. Pain 87 (2000) 109-111